Stock & Company Details
Biofrontera Inc $BFRI
Price:
N/A
N/A
15M
$13M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.84
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
BFRI technical indicators
Latest Biofrontera Inc (BFRI) indicator readings as of 2026-10-29.
BFRI's 14-day RSI is 47.9, in neutral territory. At $0.93 it is trading 9.9% below its 200-day moving average of $1.03, and below its 50-day average of $1.17. Price sits in the middle of its Bollinger Bands ($0.74 to $1.00). ADX reads 28.4, indicating a trending market.
Overview
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.
Finance Bot
Ask your questions
Start by typing a question below.
